IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $876,908 | -5.9% | 91,060 | +3.9% | 0.00% | 0.0% |
Q2 2023 | $932,312 | +2.2% | 87,600 | +1.0% | 0.00% | 0.0% |
Q1 2023 | $912,074 | +16.5% | 86,699 | +37.3% | 0.00% | 0.0% |
Q4 2022 | $782,652 | +19.7% | 63,168 | +0.1% | 0.00% | 0.0% |
Q3 2022 | $654,000 | +24.1% | 63,110 | +38.1% | 0.00% | +100.0% |
Q2 2022 | $527,000 | -54.0% | 45,700 | -39.0% | 0.00% | -96.2% |
Q4 2016 | $1,145,000 | +30.7% | 74,858 | +35.8% | 0.03% | +44.4% |
Q3 2016 | $876,000 | +21.2% | 55,136 | -0.2% | 0.02% | -5.3% |
Q2 2016 | $723,000 | -47.3% | 55,259 | -56.0% | 0.02% | -48.6% |
Q1 2016 | $1,373,000 | -3.8% | 125,484 | +1.9% | 0.04% | -21.3% |
Q4 2015 | $1,427,000 | +12.4% | 123,127 | +1.1% | 0.05% | -9.6% |
Q3 2015 | $1,270,000 | -10.9% | 121,843 | +3.1% | 0.05% | +13.0% |
Q2 2015 | $1,425,000 | -11.0% | 118,188 | +18.1% | 0.05% | -14.8% |
Q1 2015 | $1,602,000 | +29.0% | 100,100 | +23.5% | 0.05% | +20.0% |
Q4 2014 | $1,242,000 | +15.6% | 81,078 | -2.2% | 0.04% | +15.4% |
Q3 2014 | $1,074,000 | – | 82,908 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |